NGSオートメーションの市場規模、シェア、成長分析：製品タイプ別、用途別、シーケンスタイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

NGSオートメーションの世界市場規模は2023年に40万米ドルと評価され、予測期間（2025-2032年）のCAGRは13.4%で、2024年の45万米ドルから2032年には124万米ドルに成長する見通しです。

ハイスループットシーケンスとしても知られる次世代シーケンス（NGS）は、従来の手法と比較して迅速かつコスト効率の高いDNAおよびRNA分析を可能にすることで、ゲノム学と分子生物学に革命をもたらしています。高度なリキッドハンドリング装置によって促進されるNGSの自動化は、時間とコストを削減しながら、一貫性と再現性のあるデータを確保することでライブラリー調製の質を向上させる。この自動化により、サンプルと人間の相互作用が最小化されるため、コンタミネーションのリスクが減少します。効率的なワークフローへの需要が高まるにつれ、生産性を高めエラーを減らすためにNGSプロセスの自動化へのシフトが顕著になっています。NGS市場は、製品コストの高さや潜在的なリコールが市場全体の成長に影響を与えるなどの課題はあるもの、医薬品開発への応用や主要企業による包括的な製品提供が主な原動力となっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

NGSオートメーション市場規模：製品別& CAGR（2025-2032）

• 市場概要
• ワークステーション/ロボットプラットフォーム
• 試薬・消耗品

NGSオートメーション市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 創薬
• 臨床診断
• 腫瘍学
• 感染症
• 生殖に関する健康
• その他の臨床診断
• その他の用途

NGSオートメーション市場規模：シーケンスタイプ別& CAGR（2025-2032）

• 市場概要
• 全ゲノム配列解析
• 全エクソーム配列解析
• 標的ゲノムシーケンシング
• その他

NGSオートメーション市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院および診断研究所
• 製薬・バイオテクノロジー企業
• 学術調査機関
• その他エンドユーザー

NGSオートメーション市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（USA）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Roche Holding AG（Switzerland）
• Danaher Corporation（USA）
• Tecan Group Ltd.（Switzerland）
• Hamilton Company（USA）
• Eppendorf AG（Germany）
• Hudson Robotics（USA）
• 10x Genomics, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Honeywell International Inc.（USA）
• Siemens AG（Germany）
• Abbott Laboratories（USA）
• LabCorp（Laboratory Corporation of America Holdings）（USA）
• Charles River Laboratories International, Inc.（USA）
• Brooks Life Sciences（USA）

結論と推奨事項

Global NGS Automation Market size was valued at USD 0.4 million in 2023 and is poised to grow from USD 0.45 million in 2024 to USD 1.24 million by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).

Next-generation sequencing (NGS), also known as high-throughput sequencing, is revolutionizing genomics and molecular biology by enabling rapid and cost-effective DNA and RNA analysis compared to traditional methods. Automation in NGS, facilitated by advanced liquid handling devices, enhances library preparation quality by ensuring consistent and reproducible data while reducing time and costs. This automation minimizes human interaction with samples, thereby decreasing contamination risks. As the demand for efficient workflows grows, there is a notable shift towards automated NGS processes to boost productivity and reduce errors. The NGS market is primarily driven by its applications in drug development and comprehensive offerings from key industry players, despite challenges such as high product costs and potential recalls impacting overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ngs Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ngs Automation Market Segmental Analysis

Global NGS Automation Market is segmented by Product, Application, Sequencing Type, End User and region. Based on Product, the market is segmented into Workstation/Robotic Platform and Reagents & Consumables. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics and Other Applications. Based on Sequencing Type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories,Pharmaceuticaland Biotechnology Companies, Academic Research Institutes and Others End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ngs Automation Market

The global NGS automation market is primarily driven by heightened investment in healthcare infrastructure, which is essential for facilitating advancements in automated NGS workflows. Factors such as the rising prevalence of cancer, increased research and development expenditure, and escalating healthcare costs further contribute to the market's growth. Additionally, the expanding applications of next-generation sequencing and the formation of corporate partnerships aimed at enhancing library preparation methods are expected to propel the industry forward. As NGS continues to prove its efficacy in comprehensive genome analysis and the identification of novel viral variants, its role in epidemiological studies, especially in distinguishing between COVID-19, influenza, and other viruses, will be crucial. Collectively, these elements are poised to drive significant growth in the NGS automation sector in the coming years.

Restraints in the Global Ngs Automation Market

The growth of the global NGS automation market is expected to be significantly hindered by the substantial costs associated with installing automation workstations. Key challenges include regulatory hurdles and the lack of standardization in diagnostic testing, alongside the requirement for highly skilled personnel to effectively manage automation software. Additionally, various legal and ethical issues related to DNA sequencing, including concerns about identifiability, informed consent, and the potential for stigmatization, pose further barriers. These ethical dilemmas, coupled with cultural sensitivities, ultimately restrict the market's expansion and limit its overall development potential.

Market Trends of the Global Ngs Automation Market

The Global NGS Automation market is witnessing a significant upward trend, fueled by the increasing demand for streamlined and efficient sequencing processes. Automation in NGS library preparation enhances the reliability and reproducibility of data by facilitating better library quality and maximizing yields. It not only boosts productivity and cuts costs but also minimizes the risk of contamination through reduced manual handling of reagents and samples. As researchers increasingly seek high-throughput solutions to cope with growing genomic data, the NGS automation market is set to expand, driven by technological advancements and the need for stringent quality control in genetic studies and diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global NGS Automation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Workstation/Robotic Platform
• Reagents & Consumables

Global NGS Automation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Clinical Diagnostics
• Oncology
• Infectious Diseases
• Reproductive Health
• Other Clinical Diagnostics
• Other Applications

Global NGS Automation Market Size by Sequencing Type & CAGR (2025-2032)

• Market Overview
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Genome Sequencing
• Others

Global NGS Automation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Others End Users

Global NGS Automation Market Size & CAGR (2025-2032)

• North America (Product, Application, Sequencing Type, End User)
  • US
  • Canada
• Europe (Product, Application, Sequencing Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Sequencing Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Sequencing Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Sequencing Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hudson Robotics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeywell International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (Laboratory Corporation of America Holdings) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brooks Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations